Finding affordable stocks can be challenging, especially with a small budget. Stocks priced under $1, often referred to as penny stocks, provide an option for those open to taking a risk. For a broader look at trending stocks less than $1, there are curated lists to help identify speculative opportunities in this space.
This blog will share ten promising penny stocks to observe in 2025 and assist you in making well-informed decisions. Keep reading to discover which stocks could hold significant promise!
Key Factors to Consider Before Investing in Penny Stocks
Investors often turn to penny stocks for their potential growth at a low cost. These stocks, typically priced under $5 and sometimes less than $1, can be highly speculative and risky.
Grasping the fluctuations of these affordable stocks is essential, as prices can swing wildly based on news or market sentiment. Conduct thorough research before trading small-cap stocks since lack of information and lower liquidity may amplify risks.
Be mindful of stock market delisting rules, especially with Nasdaq- or NYSE-listed penny stocks like Stardust Power (NASDAQ: SDST). A failure to meet certain price thresholds could lead to removal from major exchanges, making them harder to trade.
Stick with companies showing clear growth signs, such as positive earnings reports or new product developments. *Peter Lynch famously said*, “>Know what you own and why you own it.
Top 10 Stocks Less Than $1 to Watch in 2025
Discover affordable stocks with strong growth potential in 2025. These undervalued options could appeal to both cautious and bold investors.
Stardust Power (NASDAQ: SDST)
Stardust Power (NASDAQ: SDST) focuses on renewable energy solutions. This small-cap stock has gained attention for its progress in solar technology. Its affordable share price makes it a potential option for speculative stocks under $1.
Many investors see this as an undervalued stock with growth possibilities.
The company recently expanded into emerging markets, targeting areas with high demand for clean energy. Analysts note the risky nature of penny stocks like Stardust but emphasize its position in the growing renewable energy sector.
Discover more microcap options with Invivyd next.
Invivyd (NASDAQ: IVVD)
Unlike Stardust Power, Invivyd concentrates on creating treatments for infectious diseases. This biotech company is working to develop antibody therapeutics designed to address serious illnesses like COVID-19.
Shares of Invivyd remain affordable and draw speculative investors looking for potential high-growth stocks. Its pipeline includes promising therapies, which could attract attention if they achieve development milestones.
While IVVD is one example of a speculative biotech under $1, traders looking for slightly higher-priced entries can also explore some of the best stocks under $2 for broader opportunities.
Context Therapeutics (NASDAQ: CNTX)
Context Therapeutics (NASDAQ: CNTX) focuses on developing cancer treatments. The company works on therapies targeting hormone-driven cancers, including breast and ovarian cancer.
This microcap stock trades under $1, making it an affordable option for speculative investors. As of recent reports, its clinical trials aim to address unmet needs in oncology. Traders should monitor this stock for possible growth linked to successful trial outcomes or collaborations.
Vor Biopharma (NYSE: VOR)
Vor Biopharma focuses on creating therapies for blood cancers. The company uses gene-editing technology to develop targeted treatments that reduce harm to healthy cells.
Its lead product candidate, VOR33, aims to enhance outcomes for leukemia patients undergoing stem cell transplants. Vor Biopharma’s distinct approach could position it as a promising stock in the biotech sector despite its current undervalued status.
Tenaya Therapeutics (NASDAQ: TNYA)
Tenaya Therapeutics (NASDAQ: TNYA) concentrates on creating treatments for heart disease. The company applies gene therapy, precision medicine, and stem cell research to develop therapies.
It focuses on conditions such as heart failure and cardiomyopathies.
Shares are currently trading under $1 but indicate potential for future progress. Tenaya’s pipeline includes multiple products in early clinical or preclinical stages. These projects aim to address unmet needs in cardiovascular health, an area with sustained demand.
– Oncolytics Biotech (NASDAQ: ONCY)
Oncolytics Biotech (NASDAQ: ONCY)
Oncolytics Biotech (NASDAQ: ONCY) focuses on creating therapies to treat cancer. Its lead product, pelareorep, strengthens the body’s immune response against tumors.
This biotech stock trades under $1 and draws attention for its affordable price point. Investors see promise due to ongoing clinical trials targeting breast and pancreatic cancers.
For those considering speculative stocks with strong growth opportunities, Oncolytics might be worth monitoring in 2025.
FiscalNote (NYSE: NOTE)
FiscalNote (NYSE: NOTE) provides data and analytics solutions for policy and legislative tracking. The company serves governments, businesses, and non-profits. Its tools support decision-making by offering real-time information on regulations.
The stock trades at a low price, appealing to investors seeking affordable stocks with potential. FiscalNote focuses on expanding its reach in tech-driven markets, enhancing its appeal as a speculative stock pick under $1.
Conclusion
Penny stocks can provide exciting opportunities for both new and experienced investors. These low-priced stocks come with risks but also significant rewards if chosen wisely. Research plays an important role in identifying promising options with growth potential.
Always balance risk with your financial goals before investing. Keep an eye on these stocks as they may exceed expectations in 2025!
